Biotechnology company Moderna says its current vaccine does indeed protect against the variants first identified on our shores and the UK. The company is now testing whether adding a third shot to the two-dose inoculation will improve its efficacy. Professor Shabir Madhi from Wits University's Vaccine and Infectious Diseases Analytics Research Unit, says Moderna is making an overstatement about the jab. Courtesy #DStv403
